Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
AstraZeneca
David R Spigel; Corinne Faivre-Finn; Jhanelle E Gray; David Vicente; David Planchard; Luis Paz-Ares; Johan F Vansteenkiste; Marina C Garassino; Rina Hui; Xavier Quantin; Andreas Rimner; Yi-Long Wu; Mustafa Özgüroğlu; Ki H Lee; Terufumi Kato; Maike de Wit; Takayasu Kurata; Martin Reck; Byoung C Cho; Suresh Senan; Jarushka Naidoo; Helen Mann; Michael Newton; Piruntha Thiyagarajah; Scott J Antonia